| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
RESEARCH |
School of Health Science, Griffith University Gold Coast Campus, Southport, QLD 9726, Australia
Correspondence should be addressed to T Perkins; Email: a.perkins{at}griffith.edu.au
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Whole blood and plasma levels of selenium are lower in pregnant women when compared with non-pregnant women (Mihailovic et al. 2000) and decrease as gestation proceeds (Zachara et al. 1993). In 1990, Lu reported an increased incidence of pregnancy-induced hypertension in selenium-deficient regions of China and it was later found that selenium supplementation could be used to lower this high incidence of disease. Furthermore, decreased levels of selenium have been observed in patients with PET (Rayman et al. 2003). In humans, as in other mammals, selenium depletion leads to loss of glutathione peroxidase and thioredoxin reductase activity, although to date no one has examined the placental expression of these proteins during PET and related this to selenium status.
A major limitation of the investigations into the patho-physiology of PET is the fact that the disorder does not occur naturally in animals other than humans and two species of higher order primates, the patas monkey and the lowland gorilla (Zuspan 1991, Faas & Schuiling 2001). Numerous research groups have developed a variety of rodent models that in one way or another induce similar symptoms to those seen during human PET. These include nitric oxide inhibition (Baylis & Engels 1992), low dose endotoxin administration (Faas et al. 1994), sympathetic nervous system stimulation (Kanayama et al. 1997, Khatun et al. 1999), uteroplacental ischemia (Losonczy et al. 1992), hyperinsulinemia (Podjarny et al. 1998) and spontaneously hypertensive models (Sharkey et al. 2001). In this report we have studied the pregnancies of rats fed a selenium-deficient diet and carried out preliminary biochemical analysis on placental tissues from these animals to demonstrate that changes seen in selenium-deficient rat pregnancies are similar to those seen in human placental tissues during PET.
| Materials and Methods |
|---|
|
|
|---|
Urine samples were collected by applying pressure to the bladder and collecting excreted urine with a capillary tube on days 7 and 21 and stored at 80 °C before analysis for urinary protein concentrations. Blood pressures were taken three times within 5 min on days 0, 7, 14 and 21 by tail cuff method (ABI Instruments, Sydney, Australia, using a 15 mm occlusion cuff and pulse transducer.
On day 21 pregnant rats were anesthetised using sodium pentobarbital (60 mg/kg IP) and the pups delivered by caesarean section. Placental weight, fetal number and fetal weight were recorded. Placentas and the mothers liver and kidneys were collected, weighed and stored at 80 °C before biochemical analysis. The project was approved by the Griffith University Animal Ethics committee.
Processing of tissue samples and protein estimations
All samples were weighed and homogenized in four volumes of phosphate buffered saline (PBS) containing proteolytic enzyme inhibitors (Complete-Mini, Roche, Mannheim, Germany) using an Ultra-Turex homogeniser (IKA-Werke GMBH, KG Staufen, Germany). Samples were then centrifuged for 30 min at 4000 r.p.m. and the supernatant collected for biochemical analysis. The protein concentrations of tissue homogenates was determined by the BCA Protein Assay kit (Pierce, Rockford, IL, USA) following the manufacturers recommended protocols. Urea is an interfering substance for the BCA Protein Assay kit so rat urine samples were analysed using the Coomassie Plus Protein Assay kit (Pierce) following the manufacturers recommended protocols. Bovine serum albumin (BSA) was used as the protein standard and assayed together with dilutions of placental extracts. Protein concentrations were determined from the standard curve and expressed as µg protein per ml of tissue extract (µg/ml).
Glutathione Peroxidase Assay
Glutathione peroxidase activity was determined by a modified method of Paglia and Valentine (1967). Activity was determined spectrophotometrically by coupling the oxidation of glutathione and NADPH using glutathione reductase. Briefly, 900 µl of assay mix containing 0.1 M KPi (pH 7.0), 2 mM EDTA, 0.5 U/ml glutathione reductase, 10 mM glutathione and 0.3 mM reduced NADPH was placed into a Varian CARY 50 spectrophotometer (Varian Palo Alto, CA, USA) set at 340 nm. Diluted tissue extract (50 µl of 1/10 dilution) was added to the cuvette along with 50 µl of 20 mM tert-butyl hydroperoxide, a suitable substrate for glutathione peroxidase. The decrease in A340 was determined over a 3 min period and rate calculations were performed using Varian Cary software. Glutathione peroxidase activity was standardised against protein concentrations and expressed as mmoles per minute per mg of protein (mmoles/min/mg).
Thioredoxin reductase assay
Thioredoxin reductase activity was measured spectrophotometrically in a 96-well plate using the method of Holmgren and Bjornstedt (1995). This assay measures the thioredoxin reductase- and NADPH-dependent reduction of insulin with and without thioredoxin. Briefly, 20 µl of the 1/10 diluted tissue extracts were added to 120 µl of assay mix containing 50 mM KPi, 5 mM EDTA and 0.324 mg/ml insulin in a 96 well plate. Recombinant thioredoxin (10 µl of 1.4 mg/ml) was added to one well of each sample, while a further 10 µl of assay mix was added to the second well to measure background absorbance. Each sample was assayed in at least duplicate. After incubation at 37 °C for 20 min the reaction was stopped by the addition of 50 µl of 0.4 mg/ml 5,5'-dithiobis 2-nitrobenzoic acid (DTNB) in 6 M guanidine-HCl. The plate was incubated for 10 min at room temperature in the dark and plates were then read at 412 nm. Thioredoxin reductase activity was determined by subtracting the level of spontaneous insulin reduction from the thioredoxin-, thioredoxin reductase-, NADPH-dependent reduction of insulin. Thioredoxin reductase activity was expressed as units per gram of protein (U/mg).
Superoxide dismutase assay
Total superoxide dismutase (SOD) activity was measured in triplicate, spectrophotometrically in a 96-well plate using the method of Ahmed et al.(2003). This assay is based upon the inhibition of pyrogallol oxidation, with one unit of SOD activity the amount that causes 50% inhibition of the oxidation of pyrogallol. SOD activity was measured every 5 min over 1 h at 405 nm for 20 µl of 1/100 dilution of placental tissue extract with 180 µl of Triscacodylic acid buffer (0.05 M, pH 8.2) containing 0.001 M diethylenetriamine pentaacetic acid (DTPA) and 0.2 mM pyrogallol. Superoxide dismutase activity was determined from the time-dependent inhibition of pyrogallol and expressed as units per milligram of protein (U/mg).
Lipid peroxidation assay
Lipid peroxidation levels in tissue extracts were determined using a lipid peroxidation assay kit (Calbiochem, San Diego, CA, USA), following the manufacturers recommended protocol. This assay determines lipid peroxidation levels through the reaction of malondialdehyde (MDA) and 4-hydroxy-2(E)-nonenal (4-HNE) with chromogenic reagent 1-methyl-2-phenylindole at 45 °C, which results in the production of a stable chromophore with maximal absorbance at 586 nm. Tissue extracts were incubated for 40 min with 1-methyl-2-phenylindole and 10 M methanesulphonic acid at 45 °C, samples were then cooled on ice and centrifuged at 15000 g for 10 min to obtain clear supernatant samples that were read at 586 nm. 4-HNE was used to establish a standard curve, the gradient of which indicated the molar extinction coefficient used in the equation [MDA + 4 HNE] = (sample absorbance) x 5/
with sample lipid peroxidation concentrations expressed as µmoles/mg protein.
Protein carbonyl assay
Placental extracts were analysed for protein carbonyl concentrations by the previously described ELISA method of Buss et al.(1997). This assay measures protein carbonyls in biological samples after reaction with 2,4-dinitrophenyl hydrazine (DNP). Samples are then non-specifically adsorbed onto Nunc Immunosorb plates where protein bound DNP was detected with anti-DNP-biotin-antibody labelled with streptavidin-biotinylated horseradish peroxidase. Finally, reaction with o-phenylenediamine and hydrogen peroxide in 50 mM NaHPO4 plus citric acid resulted in color development after 25 min, with absorbances read at 450 nm after stopping the reaction with sulphuric acid. Each sample was analysed in triplicate and samples were quantified by comparison with oxidized BSA standards.
Data analysis
All data was processed using the Graph Pad Prism version 3.0 (Graph Pad Software Inc, San Diego, CA, USA) statistical package with P < 0.05 considered significant. One-way analysis of variance with NewmanKeuls method for pair-wise multiple comparisons was used for analysis and Grubbs test for outliers was the basis for exclusion where appropriate.
| Results |
|---|
|
|
|---|
|
|
|
|
There were no significant changes in superoxide dismutase levels in animals receiving various selenium diets, whether pregnant or not (Table 1
).
Placental concentrations of anti-oxidant proteins
There was no significant difference in placental thioredoxin reductase activity when comparing the selenium-free animals (11.06 ± 1.84 U/mg protein) with those on a standard diet containing 239 µg/Kg selenium (11.29 ± 3.14 U/mg). Placental thioredoxin reductase activity was significantly increased to 17.01 ± 4.09 U/mg protein (P < 0.05) with selenium supplementation of 1000 µg/kg food (Table 1
). A similar trend was also seen when comparing glutathione peroxidase activity for the high selenium group (54.34 ± 6.73 mmoles/min/mg protein) with the selenium free (33.33 ± 6.11 mmoles/min/mg protein, P < 0.001) and standard diet (40.52 ± 4.87 mmoles/min/mg protein, P < 0.01) groups, with no significant difference between the latter two groups (Table 1
). There was no significant difference in the level of placental superoxide dismutase activity in the placentae of animals from each dietary group although there was a trend towards an increase in activity correlating with higher selenium intakes (Table 1
).
Placental oxidative stress
The oxidative state of placental tissues from all diet groups was measured via lipid peroxide and protein carbonyl concentrations. Placental lipid peroxidation was significantly increased with the elimination of selenium from the diet (17.92 ± 1.78 µmoles/mg) with a significant difference in MDA + 4-HNE concentrations when compared with both the standard (8.30 ± 5.52 µmoles/mg protein, P < 0.05) and high selenium (7.81 ± 3.79 µmoles/mg protein, P < 0.05) diet groups (Fig. 4A
). Protein carbonyl concentrations were elevated in the placenta by the elimination of selenium from the diet, however this increase did not reach significance (Fig. 4B
).
|
| Discussion |
|---|
|
|
|---|
Rats were fed diets containing 0 µg/kg, 239 µg/kg and 1000 µg/kg selenium for 4 weeks prior to mating. There was no increase in either blood pressure or proteinuria during this period. Animals from each dietary group were mated and their blood pressures observed weekly from day 0 to day 21 of pregnancy. There was a significant increase in the systolic blood pressure of those animals on a selenium-free diet when compared with animals on a normal rat diet or a high selenium diet. We also observed an increase in proteinuria in these animals, suggesting that selenium deprivation leads to a pre-eclamptic like condition in rats deprived of selenium. We also examined the outcomes from these pregnancies and noted a decrease in pup weights in the selenium-free group but no change in pup number or placental weight.
In order to explore the biochemistry underlying these physiological changes we examined the liver activity of key anti-oxidant proteins thioredoxin reductase, glutathione peroxidase and superoxide dismutase. There was a dose-dependent relationship between selenium intake and liver activity of thioredoxin reductase and glutathione peroxidase but no change in superoxide dismutase activity. This is to be expected as thioredoxin reductase and glutathione peroxidase are selenium-dependent enzymes and we have shown in other studies that dietary selenium intake is a simple and applicable method of altering the endogenous activity of these proteins (Venardos et al. 2004). An interesting observation during these studies was the significant decrease in both thioredoxin reductase and glutathione peroxidase activity in pregnant animals fed a standard diet compared with non-pregnant animals on the same diet. This suggests that pregnancy is associated with decreased anti-oxidant protection, perhaps due to an increased demand for selenium. In humans, selenium levels decrease as gestation proceeds (Zachara et al. 1993).
It is now generally accepted that human PET is associated with an increase in placental oxidative stress (reviewed in Redman & Sargent 2001). The levels of reactive oxygen species, products of increased biological oxidation such a lipid peroxides, protein carbonyls and nitro-tyrosine residues are all elevated in pre-eclamptic placentae. Recent work from this laboratory and that of others (Walsh & Wang 1993, Wiktor et al. 2000) has shown that key anti-oxidants such as thioredoxin reductase and glutathione peroxidase are decreased in placental tissue from pre-eclamptics, adding to the oxidative stress in these tissues which may lead to increased apoptosis and even necrosis. In this study we found that animals on selenium-free diets and those on normal diets had decreased placental expression of thioredoxin reductase and glutathione peroxidase when compared with animals supplemented with 1000 µg/kg selenium. Perhaps selenium supplementation could be a simple applicable method of alleviating placental oxidative stress in humans suffering from PET as has been shown to be the case in the Chinese study on PIH women (Han & Zhou 1994).
In rats on selenium-free diets there was a significant increase in placental oxidative stress as measured by the lipid peroxide and protein carbonyl content. The addition of selenium to the diets decreased this oxidative stress but this did not correspond to the increased expression of thioredoxin reductase and glutathione peroxidase. The expression of these proteins was similar in animals on selenium-free and normal diets yet the level of lipid peroxides was higher in selenium-free animals only. The level of protein carbonyls, a marker of protein oxidation, followed a similar trend but did not reach statistical significance. This suggests that another selenium dependent protein may be responsible for this decrease in selenium replete animals, perhaps selenoprotein P that has been shown to act as an extra-cellular glutathione peroxidase (Saito et al. 1999).
Research on PET has been hindered in the past by the lack of a suitable animal model of this complex disease. Various rodent models of PET have been explored, all of which display various symptoms analogous to human PET, but do not display the oxidative changes in the placental compartment that is a key feature of the disease. In this study we have shown that selenium deprivation is able to modulate the endogenous expression of key anti-oxidant proteins, leading to a state of placental oxidative stress resulting in physiological changes in pregnant rats similar to those seen during human PET.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Ahmed H, Schott EJ, Gauthier JD & Vasta GR 2003 Superoxide dismutases from the oyster parasite Perkinsus marinus: purification, biochemical characterization, and development of a plate microassay for activity. Analytical Biochemistry 318 132141.[CrossRef][ISI][Medline]
Baylis C & Engels K 1992 Adverse interactions between pregnancy and a new model of systemic hypertension produced by chronic blockade of endothelial derived relaxing factor (EDRF) in the rat. Clinical Experiments in Hypertension B11 117129.
Buss H, Chan TP, Sluis KB, Domigan NM, Winterbourn CC 1997 Protein carbonyl measurement by a sensitive ELISA method. Free Radical Biology and Medicine 23 361366.[CrossRef][ISI][Medline]
Di Trapani G, Perkins AV & Clarke FM 1998 Production and secretion of thioredoxin from transformed human trophoblast cells. Molecular Human Reproduction 4 369375.
Faas MM & Schuiling GA 2001 Pre-eclampsia and the inflammatory response. European Journal of Obstetrics and Gynecology and Reproductive Biology 95 213217.
Faas MM, Schuiling GA, Baller JFW, Visscher CA & Baller WW 1994 A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. American Journal of Obstetrics and Gynecology 171 158164.[ISI][Medline]
Han L & Zhou SM 1994 Selenium supplement in the prevention of pregnancy induced hypertension. Chinese Medical Journal 107 870871.[Medline]
Holmgren A & Bjornstedt M 1995 Thioredoxin and thioredoxin reductase. Methods in Enzymology 252 199208.[CrossRef][ISI][Medline]
Hubel CA 1999 Oxidative stress in the pathogenesis of preeclampsia. Proceedings for the Society of Experimental Biological Medicine 222 222235.
Kanayama N, Tsujimura R & She L 1997 Cold-induced stress stimulates the sympathetic nervous system, causing hypertension and proteinuria in rats. Journal of Hypertension 15 383389.[CrossRef][ISI][Medline]
Khatun S, Kanayama N, Belayet HM, Masui M, Sugimura M, Kobayashi T & Terao T 1999 Induction of preeclampsia like phenomena by stimulation of sympathetic nerve with cold and fasting stress. European Journal of Obstetrics and Gynecology and Reproductive Biology 86 8997.
Knapen MF, Peters WH, Mulder TP, Merkus HM, Jansen JB & Steegers EA 1999 Glutathione and glutathione-related enzymes in decidua and placenta of controls and women with pre-eclampsia. Placenta 20 541546.[CrossRef][ISI][Medline]
Losonczy G, Brown G & Venuto RC 1992 Increased peripheral resistance during reduced uterine perfusion pressure hypertension in pregnant rabbits. American Journal of Medical Science 303 233240.
Lu BY 1990 Changes of selenium in patients with pregnancy induced hypertension. Chinese Journal of Obstetrics and Gynecology 25 325.
Mihailovic M, Cvetkovic M, Ljubic A, Kosanovic M, Nedeljkovic S, Jovanovic I & Pesut O 2000 Selenium and malondialdehyde content and glutathione peroxidase activity in maternal and umbilical cord blood and amniotic fluid. Biological and Trace Element Research 73 4754.[CrossRef]
Paglia DE & Valentine WN 1967 Studies on the quantitative and qualitatitive characterisation of erythrocyte glutathione peroxidase. Journal of Laboratory and Clinical Medicine 70 158169.[ISI][Medline]
Podjarny E, Bernheim J & Katz B 1998 Chronic exogenous hyperin-sulinemia in pregnancy: a rat model for pregnancy induced hypertension. Journal of the American Society of Nephrology 9 913.[Abstract]
Rayman MP, Abou-Shakra FR, Ward NI & Redman CW 1996 Comparison of selenium levels in pre-eclamptic and normal pregnancies. Biological and Trace Elements Research 55 920.
Rayman MP, Bode P & Redman CWG 2003 Low selenium status is associated with the occurence of the pregnancy disease pre-eclampsia in women from the United Kingdom. American Journal of Obstetrics and Gynecology 189 13431349.[CrossRef][ISI][Medline]
Redman CWG & Sargent IL 2000 Placental debris, oxidative stress and pre-eclampsia. Placenta 21 597602.[CrossRef][ISI][Medline]
Redman CWG & Sargent IL 2001 The pathogenesis of pre-eclampsia. Gynecology Obstetrics and Fertility 29 518522.[CrossRef]
Saito Y, Hayashi T, Tanaka A, Watanabe Y & Suzuki M 1999 Seleno-protein P in human plasma as an extracellular phospholipid glutathione peroxidase. Journal of Biological Chemistry 274 28662871.
Sharkey LC, McCune SA, Yuan O, Lange C & Fray J 2001 Spontaneous pregnancy-induced hypertension and intrauterine growth restriction in rats. American Journal of Hypertension 14 10581066.[CrossRef][ISI][Medline]
Venardos K, Harrison G, Headrick J & Perkins A 2004 Effects of dietary selenium on glutathione peroxidase and thioredoxin reductase activity and recovery from cardiac ischemia-reperfusion. Journal of Trace Elements in Medicine and Biology (In Press).
Walsh SW 1998 Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Seminars of Reproductive Endocrinology 16 93104.
Walsh SW & Wang Y 1993 Deficient glutathione peroxidase activity in preeclampsia is associated with increased placental production of thromboxane and lipid peroxides. American Journal of Obstetrics and Gynecology 169 14561461.[ISI][Medline]
Wiktor H, Kankofer M, Zrubek H & Kotarski J 2000 Glutathione peroxidase activity in normal and preeclamptic placentas. Ginekologia Polska 71 799803.[Medline]
Zachara BA, Wardak C, Didkowski W, Maciag A & Marchaluk E 1993 Changes in blood selenium and glutathione concentrations and glutathione peroxidase activity in human pregnancy. Gynecologic and Obstetric Investigation 35 1217.[ISI][Medline]
Zuspan FP 1991 New concepts in the understanding of hypertensive diseases during pregnancy: An overview. Clinics in Perinatology 18 653659.[ISI][Medline]
This article has been cited by other articles:
![]() |
J. Kohrle, F. Jakob, B. Contempre, and J. E. Dumont Selenium, the Thyroid, and the Endocrine System Endocr. Rev., December 1, 2005; 26(7): 944 - 984. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |